This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 10:42, 21 October 2011 (Updating {{drugbox}} (changes to verified fields - updated 'CAS_number_Ref') per Chem/Drugbox validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 10:42, 21 October 2011 by CheMoBot (talk | contribs) (Updating {{drugbox}} (changes to verified fields - updated 'CAS_number_Ref') per Chem/Drugbox validation (report errors or bugs))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
Trade names | Betagan |
AHFS/Drugs.com | Monograph |
MedlinePlus | a686011 |
Pregnancy category |
|
Routes of administration | Topical (eye drops) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 20 hours |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H25NO3 |
Molar mass | 291.385 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Levobunolol (AK-Beta, Liquifilm, Betegan) is a non-selective beta blocker. It is used topically to manage glaucoma.
References
External links
- Ishibashi T, Yokoi N, Kinoshita S (2003). "Comparison of the effects of topical levobunolol and timolol solution on the human ocular surface". Cornea. 22 (8): 709–15. doi:10.1097/00003226-200311000-00001. PMID 14576520.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - Ogasawara H, Yoshida A, Fujio N, Konno S, Ishiko S (1999). "". Nippon Ganka Gakkai Zasshi. 103 (7): 544–50. PMID 10443129.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - Leung M, Grunwald J (1997). "Short-term effects of topical levobunolol on the human retinal circulation". Eye. 11 ( Pt 3): 371–6. PMID 9373479.
Drugs used for glaucoma preparations and miosis (S01E) | |||||||
---|---|---|---|---|---|---|---|
Sympathomimetics | |||||||
Parasympathomimetics |
| ||||||
Carbonic anhydrase inhibitors/ (sulfonamides) | |||||||
Beta blocking agents | |||||||
Prostaglandin analogues (F2α) | |||||||
Other agents |